Growth in 'patient-centric care' driving M&A in pharma supply chains
An explosion in M&A activity surrounding “patient-centric” approaches to healthcare is set to further reshape ...
© Kts
By Alex Lennane
The PPE crisis taught – the hard way – both governments and logistics providers as sourcing, pricing and distribution caught everyone offguard.
But those lessons appear to have been learned: companies and governments are now looking at potential arrangements for vaccines, if and when they appear.
DHL today, in partnership with MacKinsey, released a white paper, Delivering Pandemic Resilience, looking at the task in hand – which is a big one, with potential to severely disrupt if badly planned.
First, there are currently ...
Comment on this article
Warren Willey
September 04, 2020 at 11:46 amIt’s great that scientists are trying to make a vaccine against coronavirus. Maybe the American vaccine will save the world. However, it is very important to make sure that it is safe. Many people are allergic to many drugs and their components. Therefore, it is important to create a universal vaccine that will not cause an allergic reaction. Unfortunately, it takes years of experimentation and testing to create such a vaccine :(. I say this as a doctor.
In addition, morbidity statistics around the world need to be monitored at all times to avoid deterioration.